These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4299576)

  • 41. Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice.
    Sidey FM; Furman BL; Wardlaw AC
    Vaccine; 1989 Jun; 7(3):237-41. PubMed ID: 2781857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
    Oda M; Cowell JL; Burstyn DG; Manclark CR
    J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. II. Adjuvant effect for the production of reaginic antibody in the rat.
    Tada T; Okumura K; Ochiai T; Iwasa S
    Int Arch Allergy Appl Immunol; 1972; 43(2):207-16. PubMed ID: 4342866
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of hydrocortisone and x-irradiation on the lymphocytosis induced by Bordetella pertussis.
    Morse SI
    J Exp Med; 1966 Feb; 123(2):283-97. PubMed ID: 4285858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Availability and specificity of lipopolysaccharide on the surface of 56 degrees C heated Bordetella pertussis.
    Aprile MA; Wardlaw AC
    Can J Microbiol; 1973 Apr; 19(4):536-8. PubMed ID: 4121696
    [No Abstract]   [Full Text] [Related]  

  • 46. [Interaction between Bordetella pertussis vaccine and chlorpromazine in mice].
    Antmann K; Anderlik P; Ohár A; Szeri I; Bános Z
    Acta Pharm Hung; 1995 Sep; 65(5):163-6. PubMed ID: 7484163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serologic controls of anti-pertussis vaccination].
    Mynard MC; Aymé G; Triau R
    Rev Immunol Ther Antimicrob; 1969; 33(1):7-20. PubMed ID: 4181401
    [No Abstract]   [Full Text] [Related]  

  • 48. The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Jan; 15(1):87-98. PubMed ID: 3104344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis.
    Ray A; Redhead K; Selkirk S; Poole S
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):211-7. PubMed ID: 2060761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental relation between leukocytosis and other factors of Bordetella pertussis].
    Ruiz Puente J; Rivera Rivera D; González Pacheco M
    Salud Publica Mex; 1981; 23(6):613-20. PubMed ID: 6278659
    [No Abstract]   [Full Text] [Related]  

  • 51. Isolation of two protein-free and chemically different lipopolysaccharides from Bordetella pertussis phenol-extracted endotoxin.
    Le Dur A; Chaby R; Szabó L
    J Bacteriol; 1980 Jul; 143(1):78-88. PubMed ID: 6249793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of heat-labile toxin of B. pertussis on mouse blood cells: the determination of LPF (leukocytosis-promoting factor)].
    Ishida S; Kurokawa M
    Igaku To Seibutsugaku; 1972 Apr; 84(4):255-9. PubMed ID: 4340315
    [No Abstract]   [Full Text] [Related]  

  • 53. The influence of environment on the mouse weight-gain test for estimating the toxicity of Bordetella pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():319-23. PubMed ID: 5379952
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of prednisolone on the toxicity of Bordetella pertussis for mice.
    Parton R
    J Med Microbiol; 1985 Jun; 19(3):391-400. PubMed ID: 2861293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lymphocytosis-stimulating and type-specific serological activity of B. pertussis].
    Demina AA; Trofimova NP; Igonina IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Apr; 51(4):13-9. PubMed ID: 4364445
    [No Abstract]   [Full Text] [Related]  

  • 56. Adjuvant principle of pertussis vaccine in the mouse.
    Pieroni RE; Levine L
    Nature; 1966 Sep; 211(5056):1419-20. PubMed ID: 4291099
    [No Abstract]   [Full Text] [Related]  

  • 57. The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures.
    Morse SI; Bray KK
    J Exp Med; 1969 Mar; 129(3):523-50. PubMed ID: 4304138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disruption of Bordetella pertussis in the Ribi cell fractionator. 1. Effect of different pressures.
    Hollinger E; Wardlaw AC
    Can J Microbiol; 1971 Sep; 17(9):1169-74. PubMed ID: 4329814
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the protection test of pertussis vaccine. Immunization period and protectivity. 3. Influence of heat and formation on the vaccine preparation.
    Yoshioka M; Takatsu K; Kawahira M; Takahashi K
    Jpn J Microbiol; 1967 Dec; 11(4):311-21. PubMed ID: 4297909
    [No Abstract]   [Full Text] [Related]  

  • 60. [Evaluation of Bordetella strains used in the production of anti-pertussis vaccine in stationary culture].
    Castillejos Carmona R; González Pacheco M
    Salud Publica Mex; 1981; 23(6):549-53. PubMed ID: 6278653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.